Form 4: Quaker Chemical Director Michael F. Barry Reports Routine Stock Transactions and New Equity Grant

Sentiment:

Insider Transaction Report


Quaker Chemical Corp. Director Michael F. Barry has reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside a new grant of 1,198 restricted stock units as part of his 2025 compensation.

Summary

  • On May 31, 2025, Michael F. Barry, a Director of Quaker Chemical Corp. (KWR), acquired 716 shares of common stock through the conversion of restricted stock units (RSUs).
  • Concurrently on May 31, 2025, Mr. Barry acquired an additional 9 shares of common stock from the settlement of dividend equivalent rights (DERs) associated with the vesting of RSUs.
  • Following these transactions, Mr. Barry's direct beneficial ownership of Quaker Chemical common stock increased to 76,674 shares.
  • On June 1, 2025, Mr. Barry was granted 1,198 new time-based restricted stock units under the Company's Long-Term Performance Incentive Plan, as part of his 2025 non-executive director compensation.
  • These newly granted restricted stock units are scheduled to vest 100% on May 31, 2026, and will accrue dividend equivalent rights.
  • The RSUs that converted on May 31, 2025, were originally granted on June 1, 2024, and vested 100% on May 31, 2025.

Sentiment

Score: 6

Explanation: The document reports routine insider transactions related to director compensation, including vesting of prior awards and a new grant. This is a neutral to slightly positive event as it aligns director interests with shareholders, but does not indicate any new operational or financial performance.

Positives

  • The grant of new restricted stock units aligns the director's interests with long-term shareholder value.
  • The vesting and conversion of existing equity awards demonstrate the company's commitment to its long-term incentive plans for directors.

Future Outlook

The newly granted restricted stock units are set to vest on May 31, 2026, indicating future equity compensation for the director.

Management Comments

  • Restricted stock units convert into common stock on a one-for-one basis.
  • Settlement of dividend equivalent rights occurred in connection with the vesting of restricted stock units, with each right being the economic equivalent of one share of KWR common stock.
  • The time-based restricted stock units granted on June 1, 2025, are part of Quaker Houghton's non-executive directors' 2025 compensation under the Company's Long-Term Performance Incentive Plan.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, common across publicly traded companies, reflecting director compensation and equity vesting events. Such filings provide transparency into executive and director stock ownership and alignment with shareholder interests.

Stakeholder Impact

  • Shareholders: The equity grants and conversions align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

  • The 1,198 restricted stock units granted on June 1, 2025, are expected to vest on May 31, 2026.

Key Dates

DateDescription
06/01/2024Date of grant for restricted stock units that vested on May 31, 2025.
05/31/2025Transaction date for the conversion of 716 restricted stock units and 9 dividend equivalent rights into common stock; also the vesting date for previously granted RSUs.
06/01/2025Date of grant for 1,198 new time-based restricted stock units.
06/03/2025Date the Form 4 was signed by the Attorney-in-Fact.
05/31/2026Vesting date for the 1,198 restricted stock units granted on June 1, 2025.

Keywords

SEC Form 4, Quaker Chemical Corp, KWR, Insider Transaction, Director Compensation, Restricted Stock Units, Dividend Equivalent Rights, Equity Grant, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.